133
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Serum androgens and prolactin levels in patients with keratoconus

, , , , , & show all
Pages 484-488 | Received 14 Oct 2021, Accepted 17 May 2022, Published online: 09 Jun 2022

References

  • Kennedy RH, Bourne WM, Dyer JA. A 48-year clinical and epidemiologic study of keratoconus. Am J Ophthalmol. 1986;101:267–273.
  • Millodot M, Shneor E, Albou S, et al. Prevalence and associated factors of keratoconus in Jerusalem: a cross-sectional study. Ophthalmic Epidemiol. 2011;18:91–97.
  • Kymes SM, Walline JJ, Zadnik K, et al. Quality of life in keratoconus. Am J Ophthalmol. 2004;138:527–535.
  • Tatematsu-Ogawa Y, Yamada M, Kawashima M, et al. The disease burden of keratoconus in patients’ lives: comparisons to a Japanese normative sample. Eye Contact Lens. 2008;34:13–16.
  • Tan JCK, Nguyen V, Fenwick E, et al. Vision-Related quality of life in keratoconus: a save sight keratoconus registry study. Cornea. 2019;38:600–604.
  • Moschos MM, Gouliopoulos NS, Kalogeropoulos C, et al. Psychological aspects and depression in patients with symptomatic keratoconus. J Ophthalmol. 2018;2018:1–5.
  • Tuft SJ, Moodaley LC, Gregory WM, et al. Prognostic factors for the progression of keratoconus. Ophthalmology. 1994;101:439–447.
  • Edelstein Sl, DeMatteo J, Stoeger CG, et al. Report of the eye bank association of America medical review subcommittee on adverse reactions reported from 2007 to 2014. Cornea. 2016;35:917–926.
  • Rebenitsch Rl, Kymes SM, Walline JJ, et al. The lifetime economic burden of keratoconus: a decision analysis using a Markov model. Am J Ophthalmol. 2011;151:768–73 e2.
  • Krachmer JH, Feder RS, Belin MW. Keratoconus and related noninflammatory corneal thinning disorders. Surv Ophthalmol. 1984;28:293–322.
  • Gordon-Shaag A, Millodot M, Shneor E. The epidemiology and etiology of keratoconus. Epidemiology. 2012;70:7–15.
  • Loukovitis E, Sfakianakis K, Syrmakesi P, et al. Genetic aspects of keratoconus: a literature review exploring potential genetic contributions and possible genetic relationships with comorbidities. Ophthalmol Ther. 2018;7:263–292.
  • Rabbanikhah Z, Javadi MA, Rostami P, et al. Association between acute corneal hydrops in patients with keratoconus and mitral valve prolapse. Cornea. 2011;30:154–157.
  • Cristina Kenney M, Brown DJ. The cascade hypothesis of keratoconus. Cont Lens Anterior Eye. 2003;26:139–146.
  • El-Massry A, Doheim MF, Iqbal M, et al. Association between keratoconus and thyroid gland dysfunction: a cross-sectional case-control study. J Refract Surg. 2020;36:253–257.
  • Gothwal VK, Reddy SP, Fathima A, et al. Assessment of the impact of keratoconus on vision-related quality of life. Invest Ophthalmol Vis Sci. 2013;54:2902–2910.
  • Taneja M, Vadavalli PK, Veerwal V, et al. Pregnancy-Induced keratectasia - a case series with a review of the literature. Indian J Ophthalmol. 2020;68:3077–3081.
  • McKay TB, Hjortdal J, Sejersen H, et al. Endocrine and metabolic pathways linked to keratoconus: implications for the role of hormones in the stromal microenvironment. Sci Rep. 2016;6:25534.
  • Giuffrè G, Di Rosa L, Fiorino F, et al. Variations in central corneal thickness during the menstrual cycle in women. Cornea. 2007;26:144–146.
  • Vécsei PV, Kircher K, Kaminski S, et al. Immunohistochemical detection of estrogen and progesterone receptor in human cornea. Maturitas. 2000;36:169–172.
  • Yu A, Zhao W, Savini G, et al. Evaluation of central corneal thickness using corneal dynamic scheimpflug analyzer corvis ST and comparison with pentacam rotating scheimpflug system and ultrasound pachymetry in normal eyes. J Ophthalmol. 2015;2015:767012.
  • Heidari Z, Hashemi H, Mohammadpour M, et al. Evaluation of corneal topographic, tomographic and biomechanical indices for detecting clinical and subclinical keratoconus: a comprehensive three-device study. Int J Ophthalmol. 2021;14:228.
  • Mohammadpour M, Heidari Z. Pentacam. Diagnostics in ocular imaging. Springer; 2021. pp. 65–162.
  • Mohammadpour M, Heidari Z, Hashemi H, Yaseri, M, Fotouhi, A. Comparison of Artificial Intelligence-Based Machine Learning Classifiers for Early Detection of Keratoconus. Eur J Ophthalmol. 2022 May;32(3):1352–1360. doi:10.1177/11206721211073442.
  • Serdarogullari H, Tetikoglu M, Karahan H, et al. Prevalence of keratoconus and subclinical keratoconus in subjects with astigmatism using pentacam derived parameters. J Ophthal Vis Res. 2013;8:213.
  • Haggstrom M. Reference ranges for estradiol, progesterone, luteinizing hormone and follicle-stimulating hormone during the menstrual cycle. WikiJournal of Medicine. 2014;1:1–5.
  • Davison Sl, Bell R. Androgen physiology. Semin Reprod Med. 2006;24:71–77.
  • Schiebinger RJ, Chrousos GP, Cutler GB Jr., et al. The effect of serum prolactin on plasma adrenal androgens and the production and metabolic clearance rate of dehydroepiandrosterone sulfate in normal and hyperprolactinemic subjects. J Clin Endocrinol Metab. 1986;62:202–209.
  • Davey RA, Grossmann M. Androgen receptor structure, function and biology: from bench to bedside. Clin Biochem Rev. 2016;37:3–15.
  • Khandelwal P, Liu S, Sullivan DA. Androgen regulation of gene expression in human meibomian gland and conjunctival epithelial cells. Mol Vis. 2012;18:1055–1067.
  • Yin H, Luo C, Tian Y, et al. Altered expression of sex hormone receptors in keratoconus corneas. 2017.
  • McKay TB, Hjortdal J, Sejersen H, et al. Differential effects of hormones on cellular metabolism in keratoconus in vitro. Sci Rep. 2017;7:1–13.
  • Stuard Wl, Titone R, Robertson DM. The IGF/Insulin-IGFBP axis in corneal development, wound healing, and disease. Front Endocrinol (Lausanne). 2020;11:24.
  • Kalimi M, Shafagoj Y, Loria R, et al. Anti-Glucocorticoid effects of dehydroepiandrosterone (DHEA). Mol Cell Biochem. 1994;131:99–104.
  • Mahran M, Hagag M, Shouman A. Involvement of Interleukin-16 (IL-16) in allergic conjunctivitis. Aust J Basic Appl Sci. 2009;3:3266–3272.
  • Bilgihan K, Hondur A, Sul S, et al. Pregnancy-Induced progression of keratoconus. Cornea. 2011;30:991–994.
  • Anders P, Song X, György B, et al. Effect of prolactin on normal and keratoconus human corneal stromal fibroblasts in vitro. PLoS One. 2021;16: e0249344-e.
  • Sharif R, Bak-Nielsen S, Hjortdal J, et al. Pathogenesis of keratoconus: the intriguing therapeutic potential of prolactin-inducible protein. Prog Retin Eye Res. 2018;67:150–167.
  • Naderi A. Prolactin-Induced protein in breast cancer. Adv Exp Med Biol. 2015;846:189–200.
  • Sharif R, Bak-Nielsen S, Sejersen H, et al. Prolactin-Induced protein is a novel biomarker for keratoconus. Exp Eye Res. 2019;179:55–63.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.